Ignite Creation Date:
2025-12-26 @ 11:00 AM
Ignite Modification Date:
2026-01-13 @ 11:27 AM
Study NCT ID:
NCT02620306
Status:
COMPLETED
Last Update Posted:
2022-05-25
First Post:
2015-12-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomized, Double-blind, Active Control, Parallel Group, Titration, Multicenter Study to Evaluate the Efficacy and Safety of Fimasartan
Sponsor:
Boryung Pharmaceutical Co., Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-02-11
Start Date Type:
ACTUAL
Primary Completion Date:
2019-12-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-05-11
Completion Date Type:
ACTUAL
First Submit Date:
2015-12-01
First Submit QC Date:
None
Study First Post Date:
2015-12-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-24
Last Update Post Date:
2022-05-25
Last Update Post Date Type:
ACTUAL